Corrigendum to “D-morphinan analogs with favorable pharmacokinetic profiles as dual-acting antidepressants” [Europ. J. Med. Chem. 287 (2025) 117349]

IF 6 2区医学 Q1 CHEMISTRY, MEDICINAL

European Journal of Medicinal Chemistry Pub Date : 2025-03-05 DOI:10.1016/j.ejmech.2025.117447

Jing Ji, Zhengtao Hu, Fuqiang Zheng, Jiefang Zheng, Jiaxin Cheng, Nuriddinov Zayniddin, Safomuddin Abduahadi, Guan Wang, Xudong Gong, Libiao Pan, Pengcheng Li, Jiangyu Zhao, Tianwen Hu, Weiliang Zhu, Jingshan Shen, Guanghui Tian, Haji Akber Aisa, Yang He

引用次数: 0

Abstract

The authors regret:

1.Only one corresponding author's email address is currently provided in the text. The email addresses of the other two corresponding authors should also be included
2.The following structure should be inserted before Table 2, and the accompanying comments below the structure should be deleted.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Medicinal Chemistry 化学-医药化学

CiteScore

11.70

自引率

9.00%

发文量

863

审稿时长

29 days

期刊介绍： The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.